Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Preventive Services Vaccine Policy topic
No spam. Unsubscribe anytime.
Bill would let Washington Department of Health set immunization recommendations used for coverage rules
Summary
HB 2242 would let the Department of Health issue immunization recommendations that determine insurance coverage baselines (replacing sole reliance on ACIP), adjust the coverage effective date for certain preventive services, and update the Washington Vaccine Association purchasing rules; public health officials and clinicians urged passage, insurers asked for technical care on premium impacts.
Lawmakers heard public‑health and medical community support for a bill that would return more vaccine‑recommendation authority to Washington’s Department of Health and preserve coverage for preventive services under state‑regulated plans.
Committee staff said House Bill 2242 authorizes DOH to issue immunization recommendations, requires DOH to consider the Advisory Committee on Immunization Practices (ACIP) and other expert sources, and allows the department to post recommendations without undertaking formal rulemaking. The bill also moves the baseline recommendation date for certain preventive services to June 30, 2025, and requires the Insurance Commissioner to adopt rules at least as favorable to enrollees. The Washington Vaccine Association’s definition of vaccine was updated in staff summary to reference DOH recommendations and to prioritize federal discount purchasing where possible.
Supporters included the governor’s office, Insurance Commissioner Patty Kuderer, the state health secretary, the Washington chapter of the American Academy of Pediatrics, and multiple public‑health officials. They said recent federal policy changes have created confusion and that keeping preventive care coverage in state statute ensures continuity of access. Medical experts and public‑health officials cited declining immunization rates, local outbreaks (a Snohomish County measles report was mentioned), and the public‑health value of no‑cost preventive services.
Carriers and the Association of Washington Healthcare Plans urged caution, noting recent premium increases in the individual and small group markets and saying the cumulative impact of mandates can affect affordability. Several provider and public‑health witnesses urged clear, transparent DOH processes and strong interagency coordination.
No vote occurred at the Jan. 16 hearing; committee members heard a range of technical and policy concerns and questions about the interplay between DOH recommendations, federal guidance, and insurer rulemaking.
